Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 358054
                    [Title] => Vidastat: Four years and growing stronger
                    [Summary] => Therapharma recently celebrated the fourth anniversary of the simvastatin Vidastat, the pharmacoeconomic drug indicated for the treatment and management of dyslipidemia.


Vidastat, which became available in 2002, was one of the first drugs to be launched under the pharmacoeconomics campaign which aims to provide safe, effective and affordable drugs for the treatment of chronic diseases.


                    [DatePublished] => 2006-09-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 225485
                    [Title] => EDITORIAL - Cheaper by default
                    [Summary] => Thanks to the lapse of a patent and the alertness of a local pharmaceutical company, Filipinos with cholesterol problems can now buy their medicine at half the original price. An American multinational company’s patent on the drug simvastatin expired in 2002, and Filipino-owned United Laboratories jumped on the chance to produce its version, marketed at a much lower price as Vidastat.
                    [DatePublished] => 2003-10-26 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 206209
                    [Title] => High cholesterol could be in the genes
                    [Summary] => Cholesterol problems or dyslipidemia is usually considered a lifestyle disease because its cause may be lifestyle-related, brought about by a high-fat and high-calorie diet, sedentary living and smoking. 


Many are unaware though that the tendency for one to have high cholesterol could be in the genes. One may be born with the inherited defect to metabolize fats. Seven out of 1000 people are suffering from this inherited disease called familial hypercholesterolemia (FH). 


                    [DatePublished] => 2003-05-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

VIDASTAT

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 358054
                    [Title] => Vidastat: Four years and growing stronger
                    [Summary] => Therapharma recently celebrated the fourth anniversary of the simvastatin Vidastat, the pharmacoeconomic drug indicated for the treatment and management of dyslipidemia.


Vidastat, which became available in 2002, was one of the first drugs to be launched under the pharmacoeconomics campaign which aims to provide safe, effective and affordable drugs for the treatment of chronic diseases.


                    [DatePublished] => 2006-09-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 225485
                    [Title] => EDITORIAL - Cheaper by default
                    [Summary] => Thanks to the lapse of a patent and the alertness of a local pharmaceutical company, Filipinos with cholesterol problems can now buy their medicine at half the original price. An American multinational company’s patent on the drug simvastatin expired in 2002, and Filipino-owned United Laboratories jumped on the chance to produce its version, marketed at a much lower price as Vidastat.
                    [DatePublished] => 2003-10-26 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 206209
                    [Title] => High cholesterol could be in the genes
                    [Summary] => Cholesterol problems or dyslipidemia is usually considered a lifestyle disease because its cause may be lifestyle-related, brought about by a high-fat and high-calorie diet, sedentary living and smoking. 


Many are unaware though that the tendency for one to have high cholesterol could be in the genes. One may be born with the inherited defect to metabolize fats. Seven out of 1000 people are suffering from this inherited disease called familial hypercholesterolemia (FH). 


                    [DatePublished] => 2003-05-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Vidastat: Four years and growing stronger

September 14, 2006 - 12:00am

Therapharma recently celebrated the fourth anniversary of the simvastatin Vidastat, the pharmacoeconomic drug indicated for the treatment and management of dyslipidemia. Vidastat, which became available in 2002,...

Science and Environment

EDITORIAL - Cheaper by default

October 26, 2003 - 12:00am

Thanks to the lapse of a patent and the alertness of a local pharmaceutical company, Filipinos with cholesterol problems can now buy their medicine at half the original price. An American multinational company’s...

Opinion

High cholesterol could be in the genes

May 15, 2003 - 12:00am

Cholesterol problems or dyslipidemia is usually considered a lifestyle disease because its cause may be lifestyle-related, brought about by a high-fat and high-calorie diet, sedentary living and smoking. Many are...

Science and Environment